Chargement en cours...

A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations

The use of drug combinations in clinical trials is increasingly common during the last years since a more favorable therapeutic response may be obtained by combining drugs. In phase I clinical trials, most of the existing methodology recommends a one unique dose combination as “optimal,” which may r...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biom J
Auteurs principaux: Jiménez, José L., Kim, Sungjin, Tighiouart, Mourad
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7483235/
https://ncbi.nlm.nih.gov/pubmed/32150296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bimj.201900095
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!